Press Releases

2010
	FDA Clears Three Additional Antimicrobials for Use on TREK Sensititre® In Vitro Diagnostic (IVD) MIC Susceptibility Plates: Minocycline and Telavancin Used to Treat MRSA and Other Infections; and Tigecycline, Now Cleared for Streptococcus Pneumoniae Testing
2009
	TREK Diagnostic Systems Opens New U.K. Facility in East Grinstead to Meet Expanded Customer Demand for Microbiology Products
	Magellan Diagnostic Businesses to Feature Automated Systems and Diagnostic Tests at Clinical Lab Expo
	FDA Clears Caspofungin (Cancidas®) Susceptibility Testing for TREK Sensititre® YeastOne® in Vitro Diagnostics (IVD) Product Line
	TREK to Introduce New In Vitro Diagnostic and Research-Use-Only Susceptibility Products at American Society for Microbiology General Meeting, Booth 130!
2008
	TREK Diagnostic Systems Introduces First FDA-Cleared MIC Plate with D-Test and Cefoxitin Screen at the ASM 108th General Meeting
	TREK Introduces First FDA-Cleared MIC Plate to Include D-Test and Cefoxitin Screen, Used in MRSA Detection
	FDA Clears Doripenem for TREK Sensititre® In Vitro Dry Microbroth Plates used in Clinical-Diagnostic Laboratories
	Sensititre® YeastOne® Now Includes Latest Antifungal Agents: Anidulafungin and Micafungin
	Archives: 2007 Press Releases Archives: 2006 Press Releases Archives: 2005 Press Releases Archives: 2004 Press Releases